Joyce, D. P., Berger, J. S., Guttmann, A., Hasan, G., Buyon, J. P., Belmont, H. M., Salmon, J., Askanase, A., Bathon, J., Geraldino-Pardilla, L., Ali, Y., Ginzler, E. M., Putterman, C., Gordon, C., Helmick, C. G., Barbour, K. E., Gold, H. T., Parton, H., & Izmirly, P. M. (2024). Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus. Arthritis Research & Therapy, 26(1). https://doi.org/10.1186/s13075-024-03395-6

Fleischer, S., Nash, T. R., Tamargo, M. A., Lock, R. I., Venturini, G., Morsink, M., Graney, P. L., Li, V., Lamberti, M. J., Liberman, M., Kim, Y., Tavakol, D. N., Zhuang, R. Z., Whitehead, J., Friedman, R. A., Soni, R. K., Seidman, J. G., Seidman, C. E., Geraldino-Pardilla, L., … Vunjak-Novakovic, G. (2024). An engineered human cardiac tissue model reveals contributions of systemic lupus erythematosus autoantibodies to myocardial injury. Nature Cardiovascular Research, 3(9), 1123–1139. https://doi.org/10.1038/s44161-024-00525-w

Bertsias, G., Askanase, A., Doria, A., Saxena, A., & Vital, E. M. (2024). A path to Glucocorticoid Stewardship: a critical review of clinical recommendations for the treatment of systemic lupus erythematosus. Rheumatology, 63(7), 1837–1849. https://doi.org/10.1093/rheumatology/keae041

Askanase, A. D., Furie, R. A., Dall’Era, M., Bomback, A. S., Schwarting, A., Zhao, M.-H., Bruce, I. N., Khamashta, M., Rubin, B., Carroll, A., Daniels, M., Levy, R. A., van Vollenhoven, R., & Urowitz, M. B. (2024). Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations. Lupus Science & Medicine, 11(1), e001124. https://doi.org/10.1136/lupus-2023-001124

Krustev, E., Hanly, J. G., Chin, R., Buhler, K. A., Urowitz, M. B., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sánchez-Guerrero, J., Bernatsky, S., Wallace, D. J., Isenberg, D., Rahman, A., Merrill, J. T., Fortin, P. R., Gladman, D. D., Bruce, I. N., Petri, M. A., Ginzler, E. M., … Choi, M. Y. (2024). Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus. Lupus Science & Medicine, 11(1), e001139. https://doi.org/10.1136/lupus-2023-001139

Gartshteyn, Y., Geraldino-Pardilla, L., Khalili, L., Bukhari, S., Lerrer, S., Winchester, R. J., Askanase, A. D., & Mor, A. (2024). SAP-expressing T peripheral helper cells identify systemic lupus erythematosus patients with lupus nephritis. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1327437

Dong, C., Guo, Y., Chen, Z., Li, T., Ji, J., Sun, C., Li, J., Cao, H., Xia, Y., Xue, Z., Gu, X., Liang, Q., Zhao, R., Fu, T., Ma, J., Jiang, S., Wu, C., Fu, Q., Guo, G., … Gu, Z. (2024). Single‐Cell Profiling of Bone Marrow B Cells and Early B Cell Developmental Disorders Associated With Systemic Lupus Erythematosus. Arthritis & Rheumatology, 76(4), 599–613. Portico. https://doi.org/10.1002/art.42750

Merrill, J. T., Guthridge, J., Smith, M., June, J., Koumpouras, F., Machua, W., Askanase, A., Khosroshahi, A., Sheikh, S. Z., Rathi, G., Burington, B., Foster, P., Matijevic, M., Arora, S., Wang, X., Gao, M., Wax, S., James, J. A., & Zack, D. J. (2023). Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial. Arthritis & Rheumatology, 75(12), 2185–2194. Portico. https://doi.org/10.1002/art.42652

Askanase, A., Khalili, L., Tang, W., Mertz, P., Scherlinger, M., Sebbag, E., Chasset, F., Felten, R., & Arnaud, L. (2023). New and future therapies: Changes in the therapeutic armamentarium for SLE. Best Practice & Research Clinical Rheumatology, 37(4), 101865. https://doi.org/10.1016/j.berh.2023.101865

Kaplan, J., Askanase, A., Chu, D., Abdellatif, A., Basu, D., & Mirsaeidi, M. (2023). Acthar® Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence. Clinical Drug Investigation, 43(10), 739–761. https://doi.org/10.1007/s40261-023-01303-5

Connelly, K., Eades, L. E., Koelmeyer, R., Ayton, D., Golder, V., Kandane-Rathnayake, R., Gregory, K., Brunner, H., Burke, L., Arnaud, L., Askanase, A., Aranow, C., Vital, E., Pons-Estel, G., Dantata, K., Andersen, J., Cornet, A., Buie, J., … Sun, Y. (2023). Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce. Nature Reviews Rheumatology, 19(9), 592–602. https://doi.org/10.1038/s41584-023-00993-7

Hasan, G., Ferucci, E. D., Buyon, J. P., Belmont, H. M., Salmon, J. E., Askanase, A., Bathon, J. M., Geraldino-Pardilla, L., Ali, Y., Ginzler, E. M., Putterman, C., Gordon, C., Helmick, C. G., Parton, H., & Izmirly, P. M. (2022). Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program. Rheumatology, 62(8), 2845–2849. https://doi.org/10.1093/rheumatology/keac703

Shao, D., Pena, O., Sekulic, M., Valdez Imbert, R., Vegivinti, C. T. R., & Jim, B. (2023). Secondary haemophagocytic lymphohistiocytosis in a patient with new-onset systemic lupus erythematosus: the challenges of timely diagnosis and successful treatment. BMJ Case Reports, 16(7), e252938. https://doi.org/10.1136/bcr-2022-252938

Askanase, A. D., Aranow, C., Kim, M. Y., Kamen, D. L., Arriens, C., Khalili, L., Tang, W., Barasch, J., Dall’Era, M., & Mackay, M. (2023). Protocol for virtual physical examination in an observational, longitudinal study evaluating virtual outcome measures in SLE. Lupus Science & Medicine, 10(2), e000952. https://doi.org/10.1136/lupus-2023-000952

Garces, S., Karis, E., Merrill, J. T., Askanase, A. D., Kalunian, K., Mo, M., & Milmont, C. E. (2023). Improving resource utilisation in SLE drug development through innovative trial design. Lupus Science & Medicine, 10(2), e000890. https://doi.org/10.1136/lupus-2022-000890

Johnson, S. R., Gladman, D. D., Brunner, H. I., Isenberg, D., Clarke, A. E., Barber, M. R. W., Arnaud, L., Fortin, P. R., Mosca, M., Voskuyl, A. E., Manzi, S., Aranow, C., Askanase, A., Alarcón, G. S., Bae, S., Costedoat‐Chalumeau, N., English, J. A., Pons‐Estel, G. J., Pons‐Estel, B. A., … Bruce, I. N. (2022). Evaluating the Construct of Damage in Systemic Lupus Erythematosus. Arthritis Care & Research, 75(5), 998–1006. Portico. https://doi.org/10.1002/acr.24849

Guttmann, A., Denvir, B., Aringer, M., Buyon, J. P., Belmont, H. M., Sahl, S., Salmon, J. E., Askanase, A., Bathon, J. M., Geraldino‐Pardilla, L., Ali, Y., Ginzler, E. M., Putterman, C., Gordon, C., Helmick, C. G., Parton, H., & Izmirly, P. M. (2023). Evaluation of the EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Population‐Based Registry. Arthritis Care & Research, 75(5), 1007–1016. Portico. https://doi.org/10.1002/acr.24960

Mehta, B., Jannat-Khah, D., Glaser, K. K., Luo, Y., Sammaritano, L. R., Branch, D. W., Goodman, S. M., Lockshin, M., Wang, F., Ibrahim, S., & Salmon, J. E. (2023). Fetal and maternal morbidity in pregnant patients with Lupus: a 10-year US nationwide analysis. RMD Open, 9(1), e002752. https://doi.org/10.1136/rmdopen-2022-002752

Askanase, A. D., Tang, W., Zuraw, Q., Gordon, R., Brotherton, B., & Merrill, J. T. (2023). Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE. Lupus Science & Medicine, 10(1), e000875. https://doi.org/10.1136/lupus-2022-000875

Buie, J., Bloch, L., Morand, E. F., van Vollenhoven, R. F., Werth, V. P., Touma, Z., Lipsky, P., Kalunian, K., Askanase, A. D., Ines, L., Reed, C., Son, M., Franson, T., Costenbader, K., & Schanberg, L. E. (2023). Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective. Lupus Science & Medicine, 10(1), e000901. https://doi.org/10.1136/lupus-2023-000901

Yao, M., Huang, X., Guo, Y., Zhao, J. V., & Liu, Z. (2023). Disentangling the common genetic architecture and causality of rheumatoid arthritis and systemic lupus erythematosus with COVID‐19 outcomes: Genome‐wide cross trait analysis and bidirectional Mendelian randomization study. Journal of Medical Virology, 95(2). Portico. https://doi.org/10.1002/jmv.28570

Almeida-Brasil, C. C., Hanly, J. G., Urowitz, M., Clarke, A. E., Ruiz-Irastorza, G., Gordon, C., Ramsey-Goldman, R., Petri, M. A., Ginzler, E. M., Wallace, D. J., Bae, S.-C., Romero-Diaz, J., Dooley, M.-A., Peschken, C., Isenberg, D., Rahman, A., Manzi, S., Jacobsen, S., Lim, S. S., … Bernatsky, S. (2022). Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine. Lupus Science & Medicine, 9(1), e000789. https://doi.org/10.1136/lupus-2022-000789

Ugarte-Gil, M. F., Hanly, J., Urowitz, M., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sanchez-Guerrero, J., Bernatsky, S., Clarke, A. E., Wallace, D. J., Isenberg, D. A., Rahman, A., Merrill, J. T., Fortin, P. R., Gladman, D. D., Bruce, I. N., Petri, M., Ginzler, E. M., Dooley, M. A., … Alarcón, G. S. (2022). Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Annals of the Rheumatic Diseases, 81(11), 1541–1548. https://doi.org/10.1136/ard-2022-222487

Cardwell, F. S., Elliott, S. J., Chin, R., St Pierre, Y., Choi, M. Y., Urowitz, M. B., Ruiz-Irastorza, G., Bernatsky, S., Wallace, D. J., Petri, M. A., Manzi, S., Bae, S.-C., Shin, J.-M., Mak, A., Cho, J., Peschken, C. A., Ramsey-Goldman, R., Fortin, P. R., Hanly, J. G., … Clarke, A. E. (2022). Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic. Lupus Science & Medicine, 9(1), e000755. https://doi.org/10.1136/lupus-2022-000755

Askanase, A. D., & Furie, R. A. (2022). A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus. Advances in Therapy, 39(7), 3088–3103. https://doi.org/10.1007/s12325-022-02160-y

van Vollenhoven, R., Askanase, A. D., Bomback, A. S., Bruce, I. N., Carroll, A., Dall’Era, M., Daniels, M., Levy, R. A., Schwarting, A., Quasny, H. A., Urowitz, M. B., Zhao, M.-H., & Furie, R. (2022). Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria. Lupus Science & Medicine, 9(1), e000634. https://doi.org/10.1136/lupus-2021-000634

Almeida-Brasil, C. C., Hanly, J. G., Urowitz, M., Clarke, A. E., Ruiz-Irastorza, G., Gordon, C., Ramsey-Goldman, R., Petri, M., Ginzler, E. M., Wallace, D. J., Bae, S.-C., Romero-Diaz, J., Dooley, M. A., Peschken, C., Isenberg, D., Rahman, A., Manzi, S., Jacobsen, S., Lim, S., … Bernatsky, S. (2022). Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Annals of the Rheumatic Diseases, 81(3), 370–378. https://doi.org/10.1136/annrheumdis-2021-221295

Ugarte-Gil, M. F., Mak, A., Leong, J., Dharmadhikari, B., Kow, N. Y., Reátegui-Sokolova, C., Elera-Fitzcarrald, C., Aranow, C., Arnaud, L., Askanase, A. D., Bae, S.-C., Bernatsky, S., Bruce, I. N., Buyon, J., Costedoat-Chalumeau, N., Dooley, M. A., Fortin, P. R., Ginzler, E. M., Gladman, D. D., … Alarcon, G. S. (2021). Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies. Lupus Science & Medicine, 8(1), e000590. https://doi.org/10.1136/lupus-2021-000590